The Medicare value based purchasing initiative for hospitals is in full swing, and a number of other quality reporting and payment programs exist. Do they have an impact and how can they be maximized is the subject of a brief from the National Institute for Health Care Reform. (NIHCR Brief) The authors first discuss the proliferation of different measures and reports and the confusion that this can cause for payers and consumers in sorting out what is meaningful. They list several criteria for finding measures that should be considered important, including relevance to consumers to payers, validity in terms of really reflecting quality, accuracy and credibility of the results captured and the feasibility of collecting the data in an inexpensive and unobtrusive manner. Perhaps the biggest difficulty is finding measures that actually correlate with better health status and outcomes for patients. Structure, process and patient experience measures obviously do this less directly than actual outcomes. The source of data can also have a bearing on the accuracy of the measure and the cost of collecting and reporting it. Claims data, chart data, patient reported data and EHR data all have their limits. Chart data should be the most reliable, but unfortunately coding efforts aimed at higher reimbursement tend to afflict the accuracy of those as well in this era of reimbursement maximization consultants. And for many categories of patients or treatments, the number per year per hospital may be so small that statistical meaning is difficult to achieve. What is most striking is that although hospitals are already subject to the value based purchasing program, it is still not clear through solid research how much what is being measured and reported matters to ultimate quality, and it is very apparent that except for unusually informed and health literate consumers, most information is not easily assimilated by patients or even by payers.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Cano Health apparently cannot, as it declares bankruptcy due to too much debt. Building primary care centers to serve Medicare, Medicaid and commercial populations, which is Cano’s business, was hot...
February 6, 2024
Turquoise health raises a fresh $30 million in capital for its price transparency platform, as the market for funding health care companies isn’t quite dead yet.
January 24, 2024
I am co-f0under of a company that manages cell and gene therapy for health plans. Cell therapy has made a big difference for many cancer patients but like all new...
January 24, 2024
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace